Mason Carrico

Stock Analyst at Stephens & Co.

(1.81)
# 3,195
Out of 4,910 analysts
71
Total ratings
35.48%
Success rate
n/a
Average return

Stocks Rated by Mason Carrico

Vericel
Jun 16, 2025
Reiterates: Overweight
Price Target: $67
Current: $37.98
Upside: +76.41%
Illumina
May 20, 2025
Reiterates: Overweight
Price Target: $105
Current: $102.03
Upside: +2.91%
Pacific Biosciences of California
May 15, 2025
Reiterates: Overweight
Price Target: $1.8
Current: $1.62
Upside: +11.11%
10x Genomics
May 15, 2025
Reiterates: Overweight
Price Target: $14
Current: $12.99
Upside: +7.78%
Hologic
May 13, 2025
Maintains: Overweight
Price Target: $77$70
Current: $65.37
Upside: +7.08%
CareDx
May 5, 2025
Reiterates: Overweight
Price Target: $40
Current: $13.02
Upside: +207.22%
Glaukos
May 2, 2025
Maintains: Overweight
Price Target: $140$115
Current: $96.36
Upside: +19.34%
Veracyte
Mar 26, 2025
Reiterates: Overweight
Price Target: $45
Current: $23.51
Upside: +91.41%
Guardant Health
Mar 26, 2025
Reiterates: Overweight
Price Target: $55
Current: $46.25
Upside: +18.92%
Cytek Biosciences
Mar 19, 2025
Reiterates: Overweight
Price Target: $6
Current: $3.25
Upside: +84.90%
Reiterates: Equal-Weight
Price Target: $17
Current: $18.28
Upside: -6.98%
Reiterates: Overweight
Price Target: $52
Current: $43.47
Upside: +19.62%
Reiterates: Equal-Weight
Price Target: $20
Current: $4.59
Upside: +335.73%
Reiterates: Overweight
Price Target: $41
Current: $16.32
Upside: +151.23%
Reiterates: Overweight
Price Target: $125
Current: $139.92
Upside: -10.66%
Reiterates: Overweight
Price Target: $19
Current: $6.42
Upside: +195.95%